On December 7 2007 Janssen and Cilag companies have submitted a marketing Authorization Application ( MAA ) in
Europe for Dapoxetine.
Dapoxetine is a pill which treats premature ejaculation and can be taken in daily dosages or used on demand.
Janssen and Cilag are a part of the Johnson and Johnson family of companies.
Besides their work involving premature ejaculation, they also specialize in developing and marketing treatments in a number of therapeutic areas such as pain, psychiatry, neurology, gastrointestinal and fungal diseases.
Jannsen and Cilag employ over 6,000 people throughout
Europe.
The company is the outcome of the merger of two companies, Janssen Pharmaceutica and Cilag.
